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Summary It has been proposed that Natural Killer (NK) cell activity is involved in host defence against
neoplasia, and that NK cells react with or recognize the transferrin receptor (TrR) on target cells. HNK-1
expression has been related to NK cell function. Therefore, in 118 cases of non-Hodgkin's lymphoma
(NHL) we studied the occurrence and distribution of HNK-lt cells by immunohistochemistry, and
simultaneously assessed the expression of TrR on malignant cells. In NHL of intermediate or high grade
malignancy there was uniform expression of TrR on malignant cells. In low grade malignancy NHL, only
lymphocytic and lymphoplasmacytoid lymphomas were TrR negative, except for faint staining of proliferation
centres. In 23 cases of follicular lymphoma, 9 showed the absence of HNK-1 + cells in neoplastic follicles. In
16/23 cases HNK-1 + cells were present around follicles or in interfollicular areas: 8 of these cases revealed a
higher density of HNK-1 + cells at this site than inside the follicles. In 22/26 cases with high grade malignancy
NHL, HNK-1+ cells were absent or present in small density, which is different from the presence in higher
density in low grade malignancy NHL. We conclude that (i) TrR expression on NHL cells is not obligatory
related with histological class or malignancy grade of the tumour, and that (ii) HNK-1 + cells are not
universally present in areas of malignant cells, in particular in follicular lymphoma and in NHL of high grade
malignancy.
Natural killer (NK) cells, being large granular
mononuclear cells with characteristics of T lineage
lymphocytes, are able to lyse tumour cells, virus-
infected cells and undifferentiated normal cell types
without prior sensitization in vitro (Herberman,
1983; Roder & Pross, 1982). These cells may play a
potential role in host defence against tumours and
resistance to metastasis. Most NK cells are detected
by the monoclonal antibody HNK-1 (Leu 7) (Abo
& Balch, 1981). In various lymphoid organs the
numbers of HNK-1+ cells correlate with NK
activity (Roder & Pross, 1982). However, the
HNK-l+ cell population exerts heterogeneity (Abo
et al., 1983; Fast et al., 1983; Lanier & Loken,
1984). HNK-1 + cells which coexpress T lymphocyte
markers form the major part of NK cells in adult
bone marrow and lymph nodes. In contrast, in
spleen and peripheral blood a significant population
of HNK-1+ cells lacks T lymphocyte markers, but
reveals expression of the myeloid antigen Ml; this
subpopulation shows a higher NK activity than
that with T cell markers (Abo et al., 1983).
There seems to be no single target cell specificity
of NK cells (Phillips et al., 1980). It has been
claimed that the transferrin receptor (TrR) is a
target cell structure (Vodinelich et al., 1983) or is
involved in the recognition process, but this has
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recently been disputed (Dokhelar et al., 1984). TrR
is present on all metabolically active, proliferating
cells (Trowbridge & Omary, 1981). By the
interaction between NK cells and TrR, NK cells
may regulate proliferation and expansion of cell
clones, both in physiology and pathology (James &
Ritchie, 1984).
In the normal lymph node, the localization of
HNK-1+ cells is restricted to germinal centres of
secondary follicles (Hsu et al., 1983; Ritchie et al.,
1983; Si & Whiteside, 1983), in coexpression with T
cell markers (Banerjee & Thibert, 1983; Poppema et
al., 1983; Porwit-Ksiazek et al., 1983). These areas
are distinguished from other sites in the lymph
node by a confluent presence of TrR expressing
lymphocytes.
For non-Hodgkin's lymphoma (NHL) there are
some data on the presence and localization of
HNK-1+ cells (Banerjee & Thibert, 1983; Poppema
et al., 1983; Porwit-Ksiazek et al., 1983; Si &
Whiteside, 1983; Swerdlow & Murray, 1984). With
regard to TrR expression, a correlation has been
reported between the percentage of TrR expressing
cells in suspension of NHL tissue specimens and
histological class of the tumour or clinical outcome
of the disease (Habeshaw et al., 1983; Kvaliy et al.,
1984). In a first evaluation of the putative role of
NK activity to autologous tumour cells in NHL, we
did an immunohistochemical study on the presence
and distribution of HNK-1+ cells in a large series
of NHL of different histological classes. As the
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TrR is suggested to represent a target cell structure
or recognition structure for NK cells, the presence
of this receptor on pathological cells was
simultaneously investigated, and correlated with the
presence and distribution of HNK-1 + cells.
Materials and methods
Lymph nodes
The study included 118 NHL specimens presented
for histopathological diagnosis to the Institute for
Pathology. The routine analysis included
histopathology, cytology, frozen tissue section
analysis in immuno- and enzyme-histochemistry,
and electron-microscopy (described in detail
elsewhere, Kluin et al., manuscript submitted).
Each case was classified according to the Kiel
classification (Lennert & Mohri, 1978). NHL,
intermediate lymphocytic, was added: in the Kiel
classification this entity forms a part of NHL,
centrocytic. Immunohistochemical typing included
application of monoclonal anti-T lymphocyte
antibodies of the Leu series (Leu 1, Leu 2, Leu 3,
Leu 5, Becton Dickinson, Mountain View, Calif.,
USA) and OKT 6 (Ortho Diagnostic Systems Inc.,
Raritan, NJ, USA), and anti-B cell antibodies B1
(Coulter Clone, Luton, UK), BA-1 (Hybritech Inc.,
San Diego, Calif., USA) or DAKO-pan-B
(Dakopatts, Copenhagen, Denmark). These were
applied in immunoperoxidase techniques (see
below). In addition, anti-immunoglobulin light and
heavy chain antisera conjugated to fluorescein iso-
thiocyanate or tetramethyl rhodamine isothio-
cyanate were applied in (double) immuno-
fluorescence (antisera from Behringwerke,
Marburg-Lahn, W-Germany, Dakopatts or
Kallestad, Austin, TX, USA). The NHL cases are
presented in Table I. As control 10 lymph node
specimens with normal histopathology were
investigated.
Immunohistochemistry for HNK-J + cells and
expression of TrR
Part of the specimen was snap frozen and stored at
temperatures below -70°C. Cryostat sections of 4-
6jm thickness were air-dried and fixed in acetone
for 10min at room temperature, followed by rinsing
in PBS, pH 7.4. In immunoperoxidase staining a
two-step procedure was followed: (1) incubation
with antibody to HNK-1 (Leu 7, Becton Dickinson,
diluted 1:50) or to TrR (B3/25, Hybritech, diluted
1:100) in PBS with 1% (wt/vol) human serum
albumin (Behringwerke); (2) incubation with
horseradish peroxidase-conjugated rabbit immuno-
globulin to mouse immunoglobulin (Dakopatts),
diluted 1:40 in PBS with 2.5% human AB serum.
The staining was performed with 3-amino-9-
ethylcarbazole (Aldrich Chemical Co., Milwaukee,
WI, USA) and H202 in 0.1 M acetate buffer, pH
4.6 (Graham et al., 1965). Sections were embedded
in an aqueous solution of gelatin (18% wt/vol),
glycerin (50%vol/vol) and phenol (1%wt/vol). In
photography, a blue filter was applied.
The expression of TrR was scored as absent (-)
or present (+). The occurrence of HNK-1+ cells
was scored as absent (-), scattered in low density
(+, between - 50 and 200mm-2) or in moderate
to high density (+ +, between - 200 and
1000mm-2 or more). In addition the tissue
localization was evaluated.
Results
Normal lymph node
In all 10 cases investigated, there was a confluent
occurrence of TrR expressing lymphocytes in the
germinal centres of secondary follicles: primary
follicles and follicle mantle zones were negative. In
paracortical areas TrR expression was observed on
nonlymphoid cells and possibly also on a few
lymphocytes (Figure la). HNK-1+ cells were found
almost exclusively in the germinal centres, in most
cases in moderate to high density (Figure 1b).
Dependent on the sectioning of specimens there
appeared to be an uneven distribution, the most
concentrated areas being the cortical pole of the
follicle. This distribution paralleled that of T
lymphocytes (of T-helper phenotype) in the
germinal centre. Primary follicles, mantle zones of
secondary follicles and paracortical areas were
almost negative.
Non-Hodgkin's lymphoma
In histopathology, 42 cases were diagnosed as NHL
of low grade malignancy (all with B cell
phenotype), 50 as NHL of intermediate grade
malignancy (all with a diffuse pattern; 49 with B
cell phenotype and one without T or B cell markers
(denoted non-T non-B)) and 26 as NHL of high
grade malignancy (17 with T cell, 7 with B cell and
2 without T or B cell markers) (Table I). In the
majority of cases TrR expression was found on
malignant cells: in the first group 4 cases were
found negative, and in the second group 5 cases.
However, between the individual groups the
distribution differed markedly. In NHL of low
malignancy grade, 8/10 lymphocytic cases showed
foci of positive cells, other cells being negative.
Similarly, 4/9 lymphoplasmacytoid immunocytoma
cases revealed foci of TrR positive cells, whereas inHNK-1 + CELLS IN NON-HODGKIN'S LYMPHOMA 173
the other cases a diffuse presence of TrR positive
cells was found. In 22/23 follicular CBCC cases
TrR expression was found in neoplastic follicles. In
50 NHL cases of intermediate grade malignancy, a
diffuse presence of TrR positive cells was found in
42 cases, whereas foci of TrR expressing cells were
observed in 3 cases. All 26 cases of high grade
malignancy showed TrR expression on cells at
diffuse location. Representative examples of TrR
expression on NHL cells are presented in Figure 1c,
e, g and i).
HNK-l + cells were found in about two-thirds of
NHL specimens: in low grade malignancy NHL
10/42 cases were negative, in intermediate grade
malignancy NHL this was 18/50 cases and in high
malignancy grade NHL this was 8/26 cases (Table
I).
However, in NHL of low grade malignancy there
was an uneven distribution. This phenomenon was
most pronounced in CBCC follicular NHL. Out of
23 cases, 16 cases revealed HNK-I + cells around
neoplastic follicles or in interfollicular areas. In 14
cases HNK-1+ cells were found in neoplastic
follicles. A predominant occurrence of HNK-1+
cells around neoplastic follicles or in the the
interfollicular area was observed in 8 cases, and 7
cases showed a predominance in follicles. In 4 cases
the density of HNK-l + cells was similar outside
and inside follicles. Four cases were negative for
HNK-1 + positive cells.
In NHL of intermediate grade malignancy,
HNK-1 + cells, if present (32/50 cases), were almost
always observed in a diffuse distribution: in only
one case an uneven distribution was observed, and
in this case HNK-1+ cells were observed in areas
with high numbers of T lymphocytes. HNK-1 +
cells were observed in 18/26 cases of high grade
malignancy NHL: all cases showed a diffuse
Table I Expression of transferrin receptor on malignant cells and occurrence and
distribution of HNK-l + cells in non-Hodgkin's lymphomaa
Phenotype HNK-J positive cells
Histopathological non-T Transferrin receptor focal diffuse
diagnosis n T B non-B - focal diffuse - + ++ + ++
Low grade malignancy
lymphocytic 10 10 2 8 3 5 2
lymphoplasmacytoid
immunocytoma 9 9 1 4 4 1 1 3 2 2
CBCC follicularb 23 23 1 22 9 4 10
Total 42 42 4 34 4 10 8 18 4 2
Intermediate grade malignancy
CBCC diffuse 16 15 1 2 14 4 10 2
CC 10 10 1 1 8 1 1 1 7
intermediate
lyphocytic 8 8 2 2 4 4 4
CB diffuse 15 15 15 9 5 1
polymorphic
immunocytoma 1 1 1 1
Total 50 49 1 5 3 42 18 1 21 10
High grade malignancy
immunoblastic 16 7 7 2 16 2 10 4
T lymphoblastic 10 10 10 6 4
Total 26 17 7 2 26 8 14 4
aThe occurrence of HNK-1+ cells is presented as absent (-), scattered in low density
(+, between - 50 and 200mm-2) or in moderate to high density (+ +, between -200 and
1000mm-2 or higher). Abbreviations: CBCC, centroblastic/centrocytic; CC, centrocytic;
CB, centroblastic.
bThe occurrence of HNK-1 + cells in CBCC follicular is presented only for follicles.
Around neoplastic follicles and in interfollicular areas the presence was: -, 7; +, 5; + +,
11. HNK-1+ cells were absent in 4 cases, in 7 cases the density in neoplastic follicles was
higher than around or between follicles, in 8 cases the reverse distribution was found, and
in 4 cases the density in follicles was about similar to that around or between follicles.174 H.-J. SCHUURMAN et al.HNK-1 + CELLS IN NON-HODGKIN'S LYMPHOMA 175
Figure 1 Expression of transferrin receptor (TrR) on malignant cells (left figures, a, c, e, g, i) and presence of
HNK-1+ cells (right figures, b, d, f, h, j) in corresponding areas of tissue sections from normal lymph node
and non-Hodgkin's lymphoma. a, b; in normal lymph node, germinal centre cells of secondary follicles show
TrR expression; in this area there are HNK-1 t cells in moderate to high density (- 500mm-2). c, d; in a case
of lymphocytic (diffuse) NHL there is no TrR expression on malignant cells except for some foci, and HNK-
1 + cells are present in low density (- 150mm-2). e, f, g, h; in CBCC follicular NHL there is TrR expression
on malignant cells in follicles, and HNK-1 + cells in moderate to high density are found for the first case (f)
in the follicles (-750mm 2), for the second case (h) around follicles and in interfollicular areas
(- 500mm-2). i, j; in a case of T lymphoblastic NHL there is TrR expression on malignant cells at diffuse
location, and HNK-l + cells are present in low density (_ 100mm-2).176 H.-J. SCHUURMAN et al.
distribution of HNK-1 + cells. Representative
examples of the occurrence and distribution of
HNK-1 + cells are presented in Figure Id, f, h and j.
Concerning areas with mainly malignant cells,
HNK-l + cells in moderate to high density were
observed in 20/42 low grade malignancy NHL, in
11/50 intermediate grade malignancy NHL, and
4/26 high grade malignancy NHL. HNK-1+ cells in
low density were found in 12, 21 and 14 cases,
respectively. There was no relation between the
density of HNK-1' cells and T or B cell phenotype
of the tumour cells.
Discussion
In accord with TrR expression on germinal centre
cells of secondary follicles in normal lymph nodes
(Figure la), we found TrR positivity on almost all
germinal centre cell derived malignant lymphocytes
(i.e., CBCC follicular, CB and CC diffuse, Table I,
Figure le and Ig). In these cases TrR positivity is
mainly found in the malignant nodules. Other
lymphoid tumours also showed TrR expression.
Only NHL, lymphocytic and lymphoplasmacytoid
immunocytoma, were TrR negative except for foci
of TrR expressing cells (Table I, Figure ic): these
foci probably represent proliferation centres. We
conclude that, except for these two NHL subtypes of
low grade malignancy, the expression of TrR on
malignant cells is not related to histological class or
,malignancy grade of the tumour.
For the percentage of TrR positive cells in cell
suspension of NHL tissue specimens such a
relationship has been reported (Habeshaw et al.,
1983; Kvaliy et al., 1984). There are two
explanations for this discrepancy between cell
suspension and tissue section analysis:
non-malignant cells, which do not express TrR,
contribute to results of cell suspension analysis:
the number of these cells may be large in cases
of follicular lymphoma of low grade malignancy
(Kluin et al., manuscript submitted).
diffuse lymphomas of low grade malignancy
(lymphocytic and lymphoplasmacytoid
immunocytoma) are TrR negative, except for
foci mentioned above.
In a first evaluation of a putative role for NK
cell activity to autologous tumour cells in NHL, we
investigated the occurrence and distribution of
HNK-1 + cells by immunohistochemistry. The
results do not indicate such a putative involvement.
In NHL of high grade malignancy, most cases
(22/26) revealed the absence or presence in low
density of HNK-1 + cells: in NHL of low or
intermediate grade malignancy generally a larger
density was found. This occurrence apparently
parallels that of non-malignant lymphocytes
mentioned above. Moreover, the results in follicular
lymphomas can be considered. In contrast to
normal lymph nodes, NHK-1+ cells were observed
around pathological follicles or in interfollicular
areas in 16/23 cases, and in 8 cases the density
around follicles exceeded that inside the neoplastic
follicles (Figure lh). Only in 10 of the cases did the
neoplastic follicles reveal HNK-1 + cells in moderate
to high density similar to normal lymph node
follicles. These observations are in partial
discordance with preliminary data from the
literature that follicular areas of nodular NHL
contain HNK-l+ cells (Banjeree & Thibert, 1983;
Poppema et al., 1983; Porwit-Ksiazek et al., 1983).
However, the presence of HNK-1 + positive cells
mainly around nodules has been noted for some
cases of follicular lymphoma (Porwit-Ksiazek et al.,
1983; Si & Whiteside, 1983), e.g. for 4/10 cases in
the series investigated by Swerdlow & Murray
(1984). In agreement with our data, Banerjee &
Thibert (1983) and Swerdlow & Murray (1984)
have observed a low density of HNK+ cells in
NHL of high grade malignancy: this may be due to
a dilution effect reflecting a low number of residual
normal cells.
Our observations indicate that HNK-1 + cells are
not universally present in areas of malignant cells in
NHL, in particular follicular NHL and NHL of
high grade malignancy. In contrast to normal
lymph node germinal centres, we found no
indications for the presence of HNK-1 + cells
adjacent to TrR positive cells in lymphoid
malignancies: this finding does not support a
putative anti-tumour role of HNK-1 + cells in non-
Hodgkin's lymphoma. It remains to be established
whether the presence of HNK-1+ cells around
pathological follicles or in interfollicular areas
points to that role, i.e. an involvement in keeping
follicular lymphomas localized, or merely reflects
the remaining lymph node architecture.
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